4.4 Review

Pharmacogenetics of Membrane Transporters: An Update on Current Approaches

Journal

MOLECULAR BIOTECHNOLOGY
Volume 44, Issue 2, Pages 152-167

Publisher

SPRINGERNATURE
DOI: 10.1007/s12033-009-9220-6

Keywords

ABCB1; ABCC1; ABCC2; ABCG2; OATP1B3; OATP1B1; Pharmacogenetics; Membrane transporters

Funding

  1. National Cancer Institute, National Institutes of Health [N01-CO-12400, HHSN261200800001E]
  2. NIH, National Cancer Institute, Center for Cancer Research

Ask authors/readers for more resources

This review provides an overview of the pharmacogenetics of membrane transporters including selected ABC transporters (ABCB1, ABCC1, ABCC2, and ABCG2) and OATPs (OATP1B1 and OATP1B3). Membrane transporters are heavily involved in drug clearance and alters drug disposition by actively transporting substrate drugs between organs and tissues. As such, polymorphisms in the genes encoding these proteins may have significant effects on the absorption, distribution, metabolism and excretion of compounds, and may alter pharmacodynamics of many agents. This review discusses the techniques used to identify substrates and inhibitors of these proteins and subsequently to assess the effect of genetic mutation on transport, both in vitro and in vivo. A comprehensive list of substrates for the major drug transporters is included. Finally, studies linking transporter genotype with clinical outcomes are discussed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available